NovaBay Pharmaceuticals, Inc. Gains 72.42%
Wed, Aug 27, 2025 at 07:42 PM
NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT) soared at $1.55, representing a gain of 72.4%. On Wed, Aug 27, 2025, NBY:NYSEMKT hit a New 2-Week High of $1.55. The stock got featured on our News Catalysts scanner on Tue, Aug 26, 2025 at 04:51 PM in the 'INVESTOR UPDATE' category. From Wed, Aug 13, 2025, the stock recorded 50.00% Up Days and 27.27% Green Days
About NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT)
NovaBay Pharmaceuticals Inc is a biopharmaceutical company engaged in commercializing & developing non-antibiotic anti-infective products to address the unmet therapeutic needs of the eye care market. Its product categories include NEUTROX & CELLERX.
Top 10 Gainers:
- Hempacco Co., Inc. (HPCO:NASDAQ), 350%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 72.42%
- Pitanium Limited (PTNM:NASDAQ), 62.46%
- Sharps Technology, Inc. (STSS:NASDAQ), 52.52%
- Skyline Builders Group Holding Limited (SKBL:NASDAQ), 52.19%
- MongoDB, Inc. (MDB:NASDAQ), 37.96%
- Azitra, Inc. (AZTR:NYSEMKT), 35.88%
- Inno Holdings Inc. (INHD:NASDAQ), 35.86%
- Jinxin Technology Holding Company (NAMI:NASDAQ), 33.01%
- SRAX, Inc. (SRAX:NASDAQ), 32.93%